Geneuro SA (France) Today
| GNRO Stock | EUR 1.49 0.05 3.47% |
Performance13 of 100
| Odds Of DistressLess than 15
|
Geneuro SA is trading at 1.49 as of the 5th of May 2024, a 3.47 percent up since the beginning of the trading day. The stock's open price was 1.44. Geneuro SA has less than a 15 % chance of experiencing some financial distress in the next two years of operation and had a good performance during the last 90 days. Equity ratings for Geneuro SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of March 2024 and ending today, the 5th of May 2024. Click here to learn more.
GeNeuro SA, a clinical-stage biopharmaceutical company, develops drugs for the treatment of neurodegenerative and autoimmune diseases. GeNeuro SA was founded in 2006 and is headquartered in Plan-les-Ouates, Switzerland. GENEURO operates under Pharmaceuticals And Biosciences classification in France and is traded on Paris Stock Exchange. The company has 24.84 M outstanding shares. More on Geneuro SA
Geneuro SA cannot be verified against its exchange. It appears that Geneuro SA is not available for investing at the moment. Please verify the symbol is currently traded on Euronext Paris. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
RefreshGeneuro Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Geneuro SA's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Geneuro SA or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | Jesus MartinGarcia |
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Geneuro SA (GNRO) is traded on Euronext Paris in France and employs 16 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 69.56 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Geneuro SA's market, we take the total number of its shares issued and multiply it by Geneuro SA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Geneuro SA operates under Biotechnology sector and is part of Health Care industry. The entity has 24.84 M outstanding shares.
Geneuro SA has accumulated about 5.48 M in cash with (6.77 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.62.
Check Geneuro SA Probability Of Bankruptcy
Geneuro SA Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Geneuro SA market risk premium is the additional return an investor will receive from holding Geneuro SA long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Geneuro SA. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Geneuro SA's alpha and beta are two of the key measurements used to evaluate Geneuro SA's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.9 | |||
| Semi Deviation | 1.78 | |||
| Standard Deviation | 2.66 | |||
| Variance | 7.09 |
Geneuro Stock Against Markets
Picking the right benchmark for Geneuro SA stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Geneuro SA stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Geneuro SA is critical whether you are bullish or bearish towards Geneuro SA at a given time. Please also check how Geneuro SA's historical prices are related to one of the top price index indicators.
Try Other Suggestions
Be your own money manager
Our tools can tell you how much better you can do entering a position in Geneuro SA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Crypto Correlations Now
Crypto CorrelationsUse cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
| All Next | Launch Module |
Geneuro SA Corporate Management
Elected by the shareholders, the Geneuro SA's board of directors comprises two types of representatives: Geneuro SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Geneuro. The board's role is to monitor Geneuro SA's management team and ensure that shareholders' interests are well served. Geneuro SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Geneuro SA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Alois Lang | Chief Development Officer | Profile | |
| Herv Perron | Chief Officer | Profile | |
| Miguel Payr | Chief Officer | Profile | |
| David MD | Chief Officer | Profile |
How to buy Geneuro Stock?
Before investing in Geneuro SA, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Geneuro SA. To buy Geneuro SA stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Geneuro SA. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Geneuro SA stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Geneuro SA stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Geneuro SA stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Geneuro SA, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Geneuro SA?
The danger of trading Geneuro SA is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Geneuro SA is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Geneuro SA. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Geneuro SA is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Geneuro SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Complementary Tools for Geneuro Stock analysis
When running Geneuro SA's price analysis, check to measure Geneuro SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Geneuro SA is operating at the current time. Most of Geneuro SA's value examination focuses on studying past and present price action to predict the probability of Geneuro SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Geneuro SA's price. Additionally, you may evaluate how the addition of Geneuro SA to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |